We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fast and Easy Test Could Revolutionize Blood Transfusions

By LabMedica International staff writers
Posted on 27 Jan 2026

Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. More...

Although blood units have a fixed expiration date, cells from different donors age at different rates, which can affect how well transfusions work, especially in vulnerable patients. Researchers have now developed a fast, chip-based test that can rapidly evaluate red blood cell quality after storage, offering a potential new tool to better manage blood supplies.

The test, developed through a collaboration between the University of Colorado Boulder (Boulder, CO, USA) and the University of Colorado Anschutz (Aurora, CO), fits on a single microchip and is designed to deliver results in about two minutes. The device, called a surface acoustic wave hemolysis assay, uses vibrations generated on a lithium niobate wafer to mechanically stress red blood cells. As the cells heat up and rupture, the system captures information that reflects membrane strength and overall cell health.

In laboratory tests using donor red blood cells, the researchers observed that some samples hemolyzed at lower temperatures than others. These samples also showed distinct metabolite patterns previously linked to aging red blood cells. The findings, published in Lab on a Chip, suggest that older or more fragile cells break down faster under acoustic stress, making the method a potential indicator of blood quality after storage.

If validated further, the chip-based test could help blood centers allocate higher-quality units to patients who need them most, such as children or individuals with conditions like sickle cell disease who require frequent transfusions. It may also reduce waste by improving decision-making around stored blood. In addition to transfusion medicine, the researchers believe similar lab-on-a-chip systems could be adapted to screen for blood-related diseases or monitor protein and metabolite changes linked to various health conditions.

“Our vision is to have a chip the size of a dime that you can plug into your cell phone,” said Associate Professor Xiaoyun Ding, senior author of the study. “It could use your phone’s camera and an app to read out the results in just two minutes.”

Related Links:
University of Colorado Boulder
University of Colorado Anschutz


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.